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Potential for medical error: Incorrectly completed request 
forms for thyroid function tests limit pathologists’ advice to 
clinicians
Annalise E Zemlin, Louise Nutt, Lesley J Burgess, Fredeline Eiman, Rajiv T Erasmus
Laboratory quality has been historically determined by the 
accuracy of the analytical phase. Following the development of 
high-quality analytical techniques, analytical error is no longer 
the main reason for error in the laboratory testing process.1 Up 
to 68.2% of laboratory errors occur in the pre-analytical phase,2 
which refers to procedures performed neither in the clinical 
laboratory nor under the control of laboratory personnel,3,4 
e.g. completion of a laboratory request form, specimen 
identification, phlebotomy, sample handling and transportation 
to the laboratory. Post-analytical error refers to the ultimate 
check on the pre-and intra-analytical quality, including the 
reviewing pathologist providing interpretative comments, 
and the clinicians’ interpretation and reaction to the results.3,4 
Interest is growing in the assessment of clinical laboratories’ 
contribution to medical outcomes, including the evaluation of 
pre-and post-analytical errors.5
Clinical authorisation of results provides a final quality 
check of the entire pre-analytical and laboratory process, and is 
an important addition to standard quality control procedures.6 
Clinical validation of biochemistry results includes the post-
analytical addition of comments to a laboratory report; this 
should be done by a qualified person with knowledge of the 
potential pre-analytical and analytical variables that may 
influence the result.7 Providing interpretative comments, 
especially to primary care physicians, is an important duty of 
chemical pathologists.8 Owing to the paucity of clinical 
biochemistry training in undergraduate medical training 
programmes9,10 and increased specialisation of medical staff, 
interpretative comments may be useful for requesting 
physicians.6 The Royal College of Pathologists has guidelines 
for the provision of such comments.11 The Clinical Pathology 
Accreditation (CPA) Standards state that interpretation of 
results is an important component of clinical laboratories’ 
services.12 External quality assessment of interpretative 
comments is in place in the UK, Australia and Italy.8,13-17 
Clinical diagnoses are often confirmed with the use of 
laboratory results and, therefore, laboratory errors may lead to 
increased costs and unnecessary deaths.18
According to Price, ‘any test will be beneficial only if 
appropriate action is taken on the results’.19 Laboratory errors 
are important because laboratory data influence 70% of medical 
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Background. Various publications have highlighted the 
significance of laboratory errors in the pre- and post-analytical 
phases and their impact on results. Thyroid-stimulating 
hormone (TSH) is a first-line thyroid function test and, if 
abnormal, reflex thyroxine (T4) or tri-iodothyronine (T3) 
testing is requested, depending on clinical and medication 
data provided. Interpretative comments are added to all TFT 
results.
Objectives. In view of the paucity of articles describing such 
errors, we audited laboratory request forms requesting 
thyroid function tests (TFT), received from primary care 
clinics and regional hospitals at our laboratory.
Design. We assessed 482 laboratory request forms for TFT 
from primary health care clinics for specific parameters.
Results. A total of 482 forms were analysed. Medication/s 
used by the patient (74.5%) and doctor’s contact number 
(65.1%) were the most commonly incomplete parameters. Of 
the 123 patients with medication details, 62 (50.4%) were on 
thyroxine.
Conclusions. There are few studies examining the frequency 
and impact of incomplete laboratory forms on laboratory 
errors, and even fewer studies examining interpretative 
comments accompanying clinical biochemistry results. We 
studied how pre-analytical errors in completing request 
forms may lead to incorrect interpretative comments and 
inappropriate reflex testing, and so influence the quality of 
the post-analytical phase.
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diagnoses and can significantly influence the success and cost 
of patient treatment.20 These findings have led to agreement 
on the definition of a laboratory error as a defect occurring at 
any stage of the laboratory cycle,21 and this definition has been 
incorporated in ISO Technical Report 22367.22
It was previously thought that interpretative comments had 
little influence on patient outcome, but a study of numerous 
thyroid function test (TFT) requests on patients taking 
thyroxine replacement therapy showed that introducing 
interpretative comments resulted in a significant decrease in 
thyroxine under-replacement.23 A survey of general and nurse 
practitioners showed that, although interpretative comments of 
certain biochemical tests, including TFTs, are time-consuming, 
they are appreciated.24 Although interpretative comments may 
be useful for primary care physicians who may not be familiar 
with the interpretation of test results, the clinical information 
provided on the request forms may be limited or inappropriate 
and may influence the interpretative comment provided.8 
Errors in interpretative comments may be attributed to the 
absence of adequate clinical information on request forms, 
which may result in comments that are misleading or harmful 
to patients.25
We reviewed the compliance of laboratory request forms 
for TFTs received in the chemical pathology laboratory at a 
primary health care laboratory where interpretative comments 
are provided for all TFT results. We hypothesised that pre-
analytical errors would influence interpretative comments and 
have a further impact on requests for reflex testing.
Design
Ours was a retrospective collaborative study by the Division 
of Chemical Pathology, NHLS, Tygerberg Hospital, and the 
Chemical Pathology Laboratory at Green Point Laboratories. 
Green Point Laboratories receive all requests from primary 
health care clinics in the Cape Town Metropole and 
surrounding areas of the Western Cape.
Original laboratory request forms received at the Chemical 
Pathology division during a 4-day period from 27 - 30 July 
2007 requesting TFTs were manually analysed for the presence 
of parameters provided in Table I. These dates were chosen 
as they account for all TFT requests between two of the 
pathologist’s visits. Thyroid-stimulating hormone (TSH) is a 
first-line thyroid function test at this laboratory and is usually 
the only test requested. The requesting clinician may request 
a thyroxine (T4) or tri-iodothyronine (T3) test, depending on 
the clinical situation. All TFTs at this laboratory are validated 
by a chemical pathologist and released with interpretative 
comments.
Data were captured on Excel worksheets and patient 
confidentiality was maintained – patients were identified by a 
study number only. Data analysis was by basic statistics using 
the Microsoft Excel programme.
The study was approved by the Ethics Committee of the 
University of Stellenbosch and performed according to the 
Declaration of Helsinki (2000).
Results
During the study period, 482 request forms for TFTs were 
received. Fig. 1 shows the results of the request forms when 
analysed for the pre-analytical quality indicators indicated 
in Table I. The worst parameter completed by requesting 
clinicians was that of medication details; 359 (74.5%) of the 
forms lacked this parameter; 349 (65.2%) had no contact details 
for the clinician; 100 (20.8%) had no diagnosis, and 122 (25.3%) 
had a diagnosis but in an abbreviated form. Patient and clinic 
details were relatively well filled in, but this might have been 
due to most forms being pre-stamped with clinic details, 
and patient identification stickers are often used. The type of 
specimen collected was not stated on 16 (3.3%) of forms; 36 
(7.5%) did not state the date and 175 (36.3%) did not state the 
time of collection.
Conclusions
We have previously demonstrated that laboratory forms are not 
adequately completed by clinicians, and we have illustrated 
the impact on the communication of critical results in a tertiary 
care setting.26 This study shows that laboratory request forms 
Table I. Pre-analytical quality indicators examined on 
chemical pathology request forms
Identification by name and surname
Identification by hospital number
Date of birth
Gender
Ward/location where patient resides
Requesting physician’s identification
Requesting physician’s contact number/pager number
Clinical/diagnostic information 
Diagnosis present in an abbreviated form
Medications that the patient is/was taking at the time of 
specimen collection
Identification of specimen
Date of specimen collection
Time of specimen collection
Illegible handwriting
Fig. 1. Absence of parameters on laboratory request forms (N=482).
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received from primary care clinics and regional hospitals are 
also inadequately completed. Interpretative comments are 
routinely provided with all TFTs. The current use of thyroxine 
replacement therapy may influence these comments and 
should therefore be indicated on all forms. For example, a 
patient with a raised TSH and normal T4 may be reported as a 
case of subclinical hypothyroidism, when the cause may in fact 
be non-compliance or inadequate dosage if the patient were 
using thyroxine replacement therapy.
TSH is a first-line thyroid function test requested by 
clinicians at primary care clinics and regional hospitals. Our 
laboratory has its own protocol for subsequent reflex testing; 
if the TSH is abnormal, a reflex T4 and/or T3 is requested. 
Studies have found that this reflex testing permits clinicians 
to obtain a correct diagnosis faster and at less cost.4 A T4 is 
requested if the TSH is elevated in a patient not on thyroxine 
replacement therapy to differentiate subclinical from overt 
hypothyroidism. If the TSH is suppressed, a T4 is requested 
to differentiate subclinical from overt hyperthyroidism. 
If the patient is on thyroxine replacement therapy, these 
abnormal TSH values may indicate inadequate dosage/non-
compliance or overdosage respectively. A slightly decreased 
TSH may also be found in nonthyroidal illness and secondary 
hypothyroidism, and the clinical data may hint at the probable 
diagnosis. Knowledge of patients’ clinical and medication 
details is therefore important, as we do not request a T3 
in patients on thyroxine replacement therapy. If this is not 
provided, unnecessary reflex testing of T3 is requested, 
resulting in an increased turnaround time and unnecessary 
cost. Unnecessary repeat tests in a laboratory can comprise up 
to 16.8% of the total workload in an immunology hospital.27 
Knowledge of all medication details of patients, and not only 
thyroxine replacement, is also important, as many drugs can 
affect the interpretation of TFT results, and some may even 
interfere with assays (Table II).28,29
We demonstrated that incomplete laboratory request forms 
may lead to misinterpretation of results, incorrect reflex 
test requests and inappropriate interpretative comments. 
Although this study was limited to TFT request forms within 
a primary care setting, we previously showed similar results 
n an academic environment.26 We only examined patients on 
thyroxine replacement therapy, but it would also have been of 
interest to examine patients on antithyroid treatment and other 
drugs influencing thyroid functions.29
A limitation of this study is that the impact of incorrectly 
completed request forms on interpretative comments and reflex 
testing has not been quantified. This is difficult because of 
requests from numerous small outlying primary care clinics as 
well as regional hospitals. A follow-up on how these incorrectly 
completed request forms affect our services is desirable, but 
would be difficult to implement in our setting. Education of 
referring clinicians is required but would also be difficult in 
our setting as many of them are completing their community 
service in outlying primary care clinics and hospitals, resulting 
in lack of continuity in patient care.
In conclusion, quality assurance in the clinical laboratory is 
multifaceted and requires the detection of poor performance 
in the actions of each process. Errors in the analytical phase 
have been well-defined and can be compared with a gold 
standard, whereas errors in extra-analytical phases may be 
more difficult to study.30 Pre-analytical errors (e.g. absence of 
important clinical data on request forms) can have a serious 
effect on patient care by causing post-analytical errors such as 
inappropriate interpretative comments, as shown in this study.
We thank Dr M Rensburg for her help with the Excel charts.
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